Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Optinose Inc (OPTN)

Optinose Inc (OPTN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
OptiNose: Q4 Earnings Snapshot

OptiNose: Q4 Earnings Snapshot

OPTN : 1.0200 (-10.53%)
OptiNose: Q3 Earnings Snapshot

OptiNose: Q3 Earnings Snapshot

OPTN : 1.0200 (-10.53%)
OptiNose: Q2 Earnings Snapshot

OptiNose: Q2 Earnings Snapshot

OPTN : 1.0200 (-10.53%)
OptiNose (OPTN) Reports Q1 Loss, Tops Revenue Estimates

OptiNose (OPTN) delivered earnings and revenue surprises of -6.25% and 15.01%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

OPTN : 1.0200 (-10.53%)
ZVRA : 5.16 (+1.55%)
OptiNose: Q1 Earnings Snapshot

OptiNose: Q1 Earnings Snapshot

OPTN : 1.0200 (-10.53%)
OptiNose (OPTN) Reports Q4 Loss, Tops Revenue Estimates

OptiNose (OPTN) delivered earnings and revenue surprises of -6.25% and 3.12%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

OPTN : 1.0200 (-10.53%)
MTEM : 1.5700 (-4.27%)
OptiNose: Q4 Earnings Snapshot

OptiNose: Q4 Earnings Snapshot

OPTN : 1.0200 (-10.53%)
Silence Therapeutics PLC Sponsored ADR (SLN) Stock Jumps 9.3%: Will It Continue to Soar?

Silence Therapeutics PLC Sponsored ADR (SLN) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving...

SLN : 21.93 (+0.14%)
OPTN : 1.0200 (-10.53%)
HLS Therapeutics Announces Board Appointment

/CNW/ - HLS Therapeutics Inc. ("HLS" or the "Company") (TSX: HLS), a pharmaceutical company focusing on central nervous system and cardiovascular markets,...

OPTN : 1.0200 (-10.53%)
MDXH : 3.11 (-0.64%)
HLS.TO : 4.73 (-0.84%)
OptiNose (OPTN) Reports Q3 Loss, Misses Revenue Estimates

OptiNose (OPTN) delivered earnings and revenue surprises of -5.88% and 17.03%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

OPTN : 1.0200 (-10.53%)
EXAI : 4.92 (-1.60%)

Barchart Exclusives

Palantir Stock Is Down on Results, But Value Investors Can Take Advantage of This Dip
Palantir Technologies stock is down today after its Q1 results yesterday. However, investors can take advantage of this weakness by shorting out-of-the-money puts as a disciplined buy-in method. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar